YOLFTbeta
Vaxil Bio Ltd

Vaxil Bio Ltd

VXL · V · Healthcare / Biotechnology

0.11CAD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.11
Open0.11
Day Range0.11 – 0.11
52-Week Range0.13 – 0.29
Volume1.52K
Market Cap577.68K
P/E (TTM)0.97
Forward P/E0.00
EPS0.15
Dividend Yield0.00%
Beta-0.33
50-Day Avg0.1602
200-Day Avg0.1704

About

Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company is headquartered in Toronto, Canada.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Gadi Levin B.Com., C.A., CPA, M.B.A.
  • Employees0
  • Headquarters559 Briar Hill Avenue, Toronto, ON, Canada, M5N 1N1, Canada
  • Websitehttps://vaxil-bio.com

Leadership

  • Mr. Gadi Levin B.Com., C.A., CPA, M.B.A.CEO & Chairman · b. 1973
  • Mr. Alan Mark Rootenberg B.Com., B.Comm, C.A., CPAChief Financial Officer · b. 1952
  • Dr. Riva Kovjazin M.D.Senior Scientist & Member of Scientific Advisory Board

Financials

Income Statement

Currency: CAD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue----0000000000000
Cost of Revenue6.12K183.07K241.87K4.57K4.85K119.00K22.00K47.00K56.00K100.00K57.00K25.00K2.00K---
Gross Profit-6.12K-183.07K-241.87K-4.57K-4.85K-11-9.00K-22.00K-47.00K-56.00K-100.00K-57.00K-25.00K-2.00K---
Operating Expense154.81K263.18K278.14K373.59K373.41K1.66K1.06M4.53M1.76M985.00K1.04M1.29M961.00K582.00K---
Operating Income-160.93K-446.24K-520.01K-378.16K-378.26K-1.67K-1.07M-4.55M-1.80M-1.04M-1.14M-1.35M-986.00K-584.00K-254-148.00K-179.00K
EBITDA-160.93K-446.24K-520.01K-323.03K-453.80K-1.42K-1.06M-4.41M-1.76M-985.00K-1.04M-1.29M-961.00K-582.00K-252-148.00K-179.00K
Net Income-160.93K-381.75K-519.45K-428.28K-302.71K-1.85K-1.07M-4.54M-1.80M-1.05M-1.17M-1.37M-986.00K-584.00K-254-178.00K522.00K
R&D----1.31K681345.00K585.00K838.00K575.00K750.00K619.00K539.00K343.00K11412.00K-
Interest Expense-1.51K-55.13K003.00K10.00K5.00K011.00K11.00K4.00K----

Balance Sheet

Currency: CAD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets544.94K720.23K363.26K271.16K252.93K115.83K290.00K1.22M310.00K890.00K205.00K1.66M2.29M1.54M976.00K733.00K1.37M
Total Liabilities29.03K38.17K99.17K199.02K64.99K81.35K507.00K561.00K797.00K455.00K788.00K857.00K585.00K405.00K85.00K17.00K5.00K
Total Equity515.90K682.06K264.09K72.15K187.94K34.48K-217.00K656.00K-487.00K435.00K-583.00K804.00K1.70M1.14M891.00K716.00K1.36M
Cash262.22K416.15K9.74K39635.46K111.97K12.00K1.02M169.00K753.00K83.00K1.51M2.24M1.51M938.00K448.00K671.00K
Total Debt----318.93--17.00K78.00K5.00K17.00K9.00K-----
Net Debt-262.22K-416.15K-9.74K-396-35.14K-111.97K-12.00K-1.01M-91.00K-748.00K-66.00K-1.50M-2.24M-1.51M-938.00K--

Cash Flow

Currency: CAD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-145.03K-380.10K-457.76K-164.34K-383.44K-128.91K-624.00K-1.50M-1.00M-943.00K-596.00K-1.10M-1.08M-734.00K-561.00K-188.00K-158.00K
Investing Cash Flow----226.00K-1.00K1.00K165.00K---------
Financing Cash Flow407.25K539.03K83.35K155.00K418.50K404.67K461.00K2.33M115.00K1.52M-68.00K2.56M1.81M35.00K-0127.00K
Capital Expenditure05.00K32.00K030.0200164.00K000000000
Free Cash Flow-145.03K-385.10K-489.76K-164.34K-383.47K-128.91K-624.00K-1.33M-1.00M-943.00K-596.00K-1.10M-1.08M-734.00K-561.00K-188.00K-158.00K
FCF to OCF100.00%101.32%106.99%100.00%100.01%100.00%100.00%89.05%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%

Earnings

Report DateMay 31, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 31, 2012Aug 31, 2012Nov 30, 2012Feb 28, 2013May 31, 2013Aug 31, 2013Nov 30, 2013Feb 28, 2014May 31, 2014Aug 31, 2014Nov 30, 2014Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Nov 26, 2026
EPS Estimate-----------------------------------------------
EPS Actual-0.04-0.39-0.10-0.08-0.09-0.07-0.08-0.22-0.080.02-0.05-0.03-0.02-0.07-0.01-0.02-0.01-0.11-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.01-0.00-0.00-0.00-0.01-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-
Surprise-----------------------------------------------
Timing----------------------------------------------After-hours

Key Statistics & Ratios

Market Cap577.68K
Enterprise Value113.68K
Trailing P/E0.97
Forward P/E0.00
Price / Sales0.00
Price / Book0.48
EPS0.15
Book Value0.316
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-252.00K
Profit Margin0.00%
Operating Margin0.00%
Return on Equity39.89%
Return on Assets-16.59%
Shares Outstanding3.98M
Shares Float3.76M
Beta-0.33
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • May 15, 20251:50
  • Mar 10, 20161:2
  • Oct 9, 20141:7
  • Oct 30, 20121:2